ANDHealth News

ANDHealth interviews John Shanks of Kraken Coding, whose Clinical Branches platform guides clinicians through guidelines in 72 hospitals, about joining its ANDHealth+ commercialisation program.

Sekisui Chemical snares 51pc stake in Queensland homebuilder Ausbuild for $335m

Japan's Sekisui Chemical has agreed to buy a controlling 51 per cent of Brisbane homebuilder Ausbuild for $335 million, valuing the group near $670 million, with settlement due January 2027.

Blobfish appoints former Coca-Cola executive to spearhead US expansion in $4b sampling market

Critical Resources battery tech holds firm in month-long test

Critical Resources reports its solid-state pouch cell ran over a month of continuous cycling while retaining most capacity, a de-risking milestone for its solvent-free battery process as it seeks licensees.

Critical Resources battery tech holds firm in month-long test

ASX-listed Critical Resources reports its solid-state pouch cell kept three-quarters of its capacity through a month-long cycling trial, further validating its solvent-free battery manufacturing approach.

Former MYOB executive appointed DroneShield CFO as full-year committed revenue tops $250m

DroneShield names Rebecca Lowde, previously at MYOB and Afterpay, as finance chief, succeeding Carla Balanco, while revealing a $251 million full-year order book and an initial sale of its RfRecon detection device.

Motive raises $1.3B from General Catalyst, pulls IPO filing to double down on AI

Motive, the fleet software firm once called KeepTruckin, took in over $1.3 billion from General Catalyst's Customer Value Fund and scrapped its IPO filing, staying private; a General Catalyst executive joins its board.

Motive Secures More Than $1.3 Billion in Growth Financing from General Catalyst

San Francisco fleet-operations AI company Motive announced over $1.3 billion in growth funding from General Catalyst's Customer Value Fund; the investor's managing director joined its board, and Motive withdrew its S-1 filing.

Also cryptobriefing.com

Evolution Business Systems joins Pine Services Group to fuel next phase of growth

Evolution Business Systems, a Microsoft partner, has been acquired by Pine Services Group, part of Evergreen, effective 1 September. EBS keeps its name, leadership and operations; no price was disclosed.

Patriot locks up five-year access for massive Peruvian silver hunt

Peruvian-focused explorer Patriot has struck a deal with local landholders unlocking five years of drilling access at its Tassa silver project; the article also recalls a recently completed $3 million raise.

Also The Age Business

Battle heats up for Austal’s US shipbuilding arm with $1.7b rival bid from Wildcat syndicate

Austal has received an indicative US$1.25 billion offer from a Wildcat Infrastructure-led syndicate for its US shipbuilding arm, outbidding Hanwha, while heavy US losses weigh on the group.

Dela, which takes the scams out of marketplace sales, raises $1 million

Dela, a Sydney payments startup founded by Meg van der Velde, has banked slightly more than A$1m from an unidentified backer to build out its buyer-protection app for peer-to-peer second-hand sales.

Also SmartCompany·Dealroom

NSW FLIP Opens Applications for Women Founders in 2026

Applications are open for the second 2026 intake of NSW FLIP, a free program offering training, mentoring and possible seed funding to women founders across New South Wales, run by the University of Newcastle.

Thoma Bravo backs bootstrapped Australian HR platform Tanda after 14 years

Growth equity firm Thoma Bravo has invested in Tanda, a Brisbane workforce-management software business, its first external funding after 14 years of bootstrapping; the money targets AI features and overseas expansion.

Three's a party! Medtech BCAL woos Genetic Signatures, Sonic's Microba

Street Talk reports BCAL Diagnostics' takeover plan for Genetic Signatures collapsed once the target's talks with Sonic-backed Microba surfaced, with a three-company combination now under discussion.

Ellerston inks $1b deal to sell NOJA to Goldman Sachs Alternatives

Ellerston has agreed to sell Queensland electrical equipment maker NOJA Power to Goldman Sachs Alternatives, signing a deal that values the company at more than $1 billion for a controlling stake.

NextDC raises $790M in convertible notes, its third capital raise in four months

NextDC, an Australian operator of data centres, announced a A$1.1 billion convertible note offer, following April equity and May debt raises, to bankroll local expansion.

US health agency funds broad access trial for Melbourne biotech's ALS drug

America's NIH has agreed to fund a program giving up to 200 ALS patients access to Neurizon Therapeutics' drug NUZ-001, with Melbourne-based Neurizon as subawardee and a Boston ALS centre running it.

OncoSil marks a milestone moment for pancreatic cancer patients in Spain

OncoSil Medical says a Madrid hospital has treated its 100th Spanish pancreatic cancer patient with its brachytherapy device, as the ASX-listed company focuses on deepening use across its 11 treatment sites.

Lexaria raises $5.9M by repricing warrants to extend runway into 2027

Lexaria Bioscience agreed immediate warrant exercises to raise about $5.9 million gross, cutting exercise prices, with H.C. Wainwright placing; proceeds plus an Australian tax rebate may carry operations and R&D into 2027.

Flavour Makers buys New Zealand's Groenz in first move offshore

Australian food manufacturer Flavour Makers has bought New Zealand condiments maker Groenz, its first acquisition beyond Australia, adding a Wellington plant, about 90 staff, 165 products and the Frenchmaid brand; terms undisclosed.

EVP launches 40x to support software startup founders looking to raise

EVP has launched 40x, a peer network for revenue-generating software startups in Australia and New Zealand planning to fundraise within a year, led by Mark Zmarzly; applications close mid-September.

Hearing Australia acquires ear wax removal clinic network Earworx in push for integrated care

Australia's national hearing services provider has bought Earworx, a nurse-led ear wax removal clinic group founded in Tasmania, adding ear wax removal to its integrated care offering.

Catalyst Accelerator Offers New Program: Investment Readiness Boot Camp

Colorado Springs defense accelerator Catalyst is taking applications for a new October 2026 boot camp preparing six to eight pre-Series A space technology companies for investment.

Built by a builder: TradeCraft goes live for apprentice tradies

Hyper announces the launch of TradeCraft, an app giving apprentice tradies site-ready video guidance, built by Luke Chiocci through Hyper's Accelerate and Launch Ready programs, with pilots and partnerships underway.

Bioshore closes Australia's first medtech-only VC fund at $27M

Bioshore Ventures has wrapped up its first fund at $27 million with all capital committed, drawing 65 individual backers including three well-known investors, and has named four health-technology companies in its portfolio.

Innovaero locks in $29M IPO ahead of $158M ASX debut

Perth drone maker Innovaero has completed the raising for its stockmarket float and will debut on the national exchange on 22 September, with an implied value near A$158 million.

Also This Week in Australian Startups

Firmus lands OpenAI deal for Malaysian data centres

Firmus will supply computing capacity to OpenAI from two planned Malaysian data centres, but sceptical investors say the deal is too small ahead of a potential float valuing the start-up at $15.5 billion.

Drone manufacturer SYPAQ Systems secures CASA approval for broad area BVLOS program

Drone maker SYPAQ Systems has won regulator approval to self-authorise beyond-visual-line-of-sight flights across Australia; the piece also recalls its Corvo X system entering service under the Australian Army's DEF129 program.

AI hotshot Firmus tees up IPO meetings after OpenAI win in Malaysia

Street Talk column reports AI cloud firm Firmus Technologies will soon market a planned ASX float to investors, with a debut tipped imminently, after a Malaysian win involving OpenAI.

Gilmour Space Technologies, Hypersonix sign hypersonic flight-test options agreement

Gilmour Space and Hypersonix have signed a partnership to offer hypersonic flight testing, combining rocket launch and scramjet technology, announced at a National Reconstruction Fund event in Canberra to build sovereign capability.

OncoSil Medical wins major investor backing to take its cancer device global

OncoSil Medical has raised $5.6m from three large existing shareholders to fund overseas and domestic launches of its radiation therapy, after winning TGA and FDA clearances for pancreatic and bile duct cancer use.

Australia's Fintech Investment Surge: What Driving the 2026 Growth

Fintech investment in Australia rebounded in H1 2026 on large deals, including two crypto acquisitions, while the government unveiled a Financial Innovation Strategy and a new industry map counted 800 fintechs.

Neurizon Therapeutics appoints Chris Bremer as chief executive to steer ALS drug through final trial stage

Neurizon Therapeutics, a Melbourne biotech developing an ALS treatment, has appointed industry veteran Dr Chris Bremer as CEO as its lead drug NUZ-001 heads toward Phase 2/3 trial results in 2027.

Arovella Therapeutics moves 'off-the-shelf' cell therapy from lab to patients

Arovella Therapeutics has produced its first clinical batch of ALA-101, a donor-derived cell therapy for blood cancer, and begun trials at a Melbourne hospital, with the first patient expected to be dosed this month.

Funding Boost for First Nations Financial Support

FBR raises $4m to fund commercialisation of robotic welding and bricklaying technology

Perth-listed robotics firm FBR announced a $4 million equity raise, mixing a share placement with a shareholder purchase plan, to finish testing its Mantis welder, roll out Hadrian bricklaying tech and repay debt.

Q2 2026 Global Fund Newsletter

Quarterly report from the Defender Global Fund flagging an 84.7% portfolio return, profits taken on SharonAI following its February Nasdaq uplisting, SharonAI's GPU collaboration with NVIDIA, and fresh investor subscriptions.

Q2 2026 Global Fund Newsletter

Defender's quarterly newsletter reports an exceptional quarter for its global fund, headlined by portfolio holding SharonAI, which surged after a February Nasdaq uplisting and an NVIDIA GPU deployment partnership.

Also Defender AM portfolio·Startup Daily

ReNerve, RMIT win $360K grant for nerve regeneration research

Australian biotech ReNerve and RMIT received a government grant of nearly AUD500,000 for a joint project aiming to speed nerve repair after prostate operations, under a federal program.

Australian SAF startup raises $22M with Qantas, Airbus backing

Qantas and Airbus backed an unnamed Australian company's A$30 million raise to advance a Queensland plant that would make lower-carbon jet fuel.

NuEnergy Gas raises $2.2M for Indonesian gas push

NuEnergy Gas, an ASX-listed gas company, has secured commitments for a A$3.1 million private placement to fund early gas sales at Tanjung Enim in Indonesia and advance other contract areas.

Canadian pensions giant seeks to sell electricity retailer Flow Power

OPTrust has tasked Lazard Australia with auctioning Flow Power, the Melbourne-founded green energy retailer it has majority-owned for eight years, with first bids due within a month.

ID Digest: Bumi Resources aquires Loyal Metals; Indonet bags $530m financing

Bumi's Australian unit has taken over ASX-listed Loyal Metals for A$79.1 million, with the shares to be delisted; separately, Indonet signed a $530.2 million loan for its subsidiary's data centre build.

He's quietly invested in Australia's biggest space tech startups. Now he's moving to launch a $150m fund

Profiles space investor Will Scully-Power, whose Pine Gap firm backs Australian space startups and plans a larger US fund with partners; defence VC Beaten Zone has also wrapped up a $26 million fund.

Oleyn lands angel funding from Singapore, Australia backers

Oleyn, an enterprise AI company, has secured backing from angel investors in Singapore and Australia, with banker Mamun Rashid among them, to support product development, hiring and overseas growth.

Sydney brothers' data centre supplier eyes $1b-plus val as PE dials in

Street Talk reports EQT Partners has bid for Parratech, the Sydney brothers Jason and Stephen Fooks' data centre enclosure business, in a deal valuing it above $1 billion; other suitors remain.

Continental AG calls Sunday board huddle to anoint mycar's new owner

Continental's board meets to choose a buyer for its Australian tyre and auto chain mycar, with Allegro Funds favoured; the German giant paid $350 million for the business eight years ago.

Zenith Payments have appointed Anthony Drury as Chief Executive Officer

Payments group Zenith Payments has named Anthony Drury its new CEO. Kevin Butler moves from the top job into a Chief Payments Officer role, while James Swan became CFO in July.

Melbourne biotech ImmunoBiota progresses $5m seed raise for world-first oral Type 1 diabetes therapy

Melbourne biotech ImmunoBiota courts investors for its still-open seed round around an oral Type 1 diabetes therapy; its recent Diabetes Australia award is recorded, while the flagged Series A and listing remain plans.